Brief: Outlook Therapeutics Announces Pricing Of $13.0 Million Public Offering
23/05/2025 11:51
May 23 (Reuters) - Outlook Therapeutics Inc OTLK.O: OUTLOOK THERAPEUTICS® ANNOUNCES PRICING OF $13.0 MILLION PUBLIC OFFERING OUTLOOK THERAPEUTICS INC - COMBINED PUBLIC OFFERING PRICE SET AT $1.40 Source text: ID:nGNX58pqSb Further company coverage: OTLK.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Outlook Therapeutics
See all newsBrief: Outlook Therapeutics Appoints Kevin Lundquist As Chief Financial Officer As It Prepares For U.S. Commercial Launch Of Lytenava™
Outlook Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Outlook Therapeutics Q3 net loss narrows slightly as costs drop
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce